Show
Sort by
-
Update to the Belgian follow-up guidelines for abnormal cervical screening results
-
Highlights in genitourinary cancers
-
Guidelines for the detection of NTRK fusions : a report from the Belgian Molecular Pathology Working Group
-
Standard of care in 2021 for patients with ovarian cancer in Belgium
-
Genetic testing in prostate cancer in clinical practice
-
PIK3CA in breast cancer : a Belgian practical testing guideline
-
Role of the pharmacist in oncology : pharmaceutical care for patients treated with oral anticancer drugs
-
An update on the management of metastatic clear-cell renal cell carcinoma : the BSMO expert panel recommendations
-
Integration of oncology and palliative care: summary of the Lancet Oncology Commission Paper.
-
Not just a 'usual' Li-Fraumeni syndrome
-
- Journal Article
- A2
- open access
Introducing a castrate resistant prostate cancer (CRPC) model care pathway in Belgian hospitals : towards national standardization?
-
Difficulties in diagnosis and treatment of a rare malignancy, malignant peritoneal mesothelioma
-
The strategic plan for paediatric cancer treatment in Belgium
-
Algorithms for molecular testing in solid tumours
-
Molecular test algorithms for breast tumours
-
- Miscellaneous
- open access
Highlights in genitourinary cancers
-
Pharmacological restoration of tumour suppressor protein p53 in neuroblastoma : seeking synergy and non-invasive biomarkers
-
Congress highlights : ASCO 2018 special edition : highlights in genitourinary cancers
-
Congress highlights : ESMO 2018 special edition : highlights in genitourinary cancers
-
PD-L1 testing for non-small cell lung cancer : Belgian guidelines